Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice– Results from the EuroSpA Collaboration
14/08/2023
Lykke Midtbøll Ørnbjerg1, Stylianos Georgiadis 2, Lennart Jacobsson 3, Anne Gitte Loft 4, Florenzo Iannone 5, Burkhard Moeller 6, Joe Sexton 7, Herman Mann 8, Maria José Santos 9, Manuel Pombo-Suarez 10, Kari K. Eklund 11, Matija Tomsic 12, Bjorn Gudbjornsson 13, Sükran Erten 14, Catalin Codreanu 15, Irene van der Horst-Bruinsma 16, Johan Wallman 17, Marco Sebastiani 18, Michael J. Nissen 19, Eirik Kristianslund 20, Karel Pavelka 8, Elsa Vieira-Sousa 21, Carlos Sánchez-Piedra 22, Nina Trokovic 2
ACR 2019
Ørnbjerg L, Georgiadis S, Jacobsson L, Loft A, Iannone F, Moeller B, Sexton J, Mann H, Santos M, Pombo-Suarez M, Eklund K, Tomsic M, Gudbjornsson B, Erten �, Codreanu C, van der Horst-Bruinsma I, Wallman J, Sebastiani M, Nissen M, Kristianslund E, Pavelka K, Vieira-Sousa E, Sánchez-Piedra C, Trokovic N, Rotar Z, Love T, Yolbas s, IONESCU R, van de Sande M, Jones G, Michelsen B, Østergaard M, Lund Hetland M. Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice– Results from the EuroSpA Collaboration [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/predictors-of-dapsa28-remission-at-6-months-in-bio-naive-patients-with-psoriatic-arthritis-starting-a-tnf-inhibitor-in-clinical-practice-results-from-the-eurospa-collaboration/
https://acrabstracts.org/abstract/predictors-of-dapsa28-remission-at-6-months-in-bio-naive-patients-with-psoriatic-arthritis-starting-a-tnf-inhibitor-in-clinical-practice-results-from-the-eurospa-collaboration/